ANI Pharmaceuticals Inc (ANIP)
Quick ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 221,121 | 48,228 | 100,300 | 7,864 | 62,332 |
| Short-term investments | US$ in thousands | — | — | — | — | — |
| Receivables | US$ in thousands | 162,079 | 165,438 | 128,526 | 95,793 | 72,129 |
| Total current liabilities | US$ in thousands | 145,477 | 99,439 | 87,537 | 78,565 | 61,676 |
| Quick ratio | 2.63 | 2.15 | 2.61 | 1.32 | 2.18 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($221,121K
+ $—K
+ $162,079K)
÷ $145,477K
= 2.63
The quick ratio of ANI Pharmaceuticals Inc has shown some fluctuations over the past five years. In 2023, the quick ratio improved significantly to 2.75 compared to 2.27 in 2022, indicating an increase in the company's ability to cover its short-term liabilities with its most liquid assets excluding inventory. This improvement suggests a stronger liquidity position in the most recent year.
Looking back at 2021 and 2019, ANI Pharmaceuticals Inc also demonstrated good liquidity positions with quick ratios of 2.74 and 2.26, respectively, which indicates the company's consistent ability to meet its short-term obligations with its quick assets. However, there was a notable drop in the quick ratio in 2020 to 1.39, which may have raised concerns about the company's ability to cover its short-term liabilities at that time.
Overall, the upward trend in the quick ratio of ANI Pharmaceuticals Inc from 2020 to 2023 indicates an improvement in the company's liquidity position over the years. It suggests that the company may have effectively managed its short-term assets and liabilities to enhance its financial stability and ability to meet its immediate obligations.
Peer comparison
Dec 31, 2023